Fresenius Medical Care Australia Pty Ltd v Gambro Pty Ltd

The case of Fresenius Medical Care Australia Pty Ltd v Gambro Pty Ltd involves allegations of patent infringement concerning various claims of a patent related to a dialysis fluid mixing system. The dispute was heard in the Federal Court of Australia, where the primary judge found Gambro Pty Ltd to have infringed certain claims of the patent held by Fresenius Medical Care Australia Pty Ltd. The appeal was brought by Gambro against the primary judge's decision, which upheld the findings of infringement.

The legal issues before the court were primarily focused on whether the patent claims were validly granted and if Gambro's products and processes infringed those claims. The court had to examine the scope and interpretation of the patent claims, the prior art, and whether Gambro's biBag system indeed infringed the patented method for mixing dialysis fluid. The court also considered the specific elements of the patent claims and whether these elements were present in Gambro's technology.

The Federal Court upheld the primary judge's findings of infringement. The court held that the biBag system employed by Gambro did infringe the claims of the patent, as it essentially replicated the method of mixing dialysis fluid as described in the patent. The court found that the biBag system used a similar process of combining A and B concentrates to produce dialysis fluid, which matched the steps outlined in the patent claims. The appeal against the findings of infringement was thus dismissed by the court.

As a result of the court's decision, the case was stood over to allow the parties to consider and agree on the appropriate orders to be made, including orders regarding costs. The court ordered that the parties provide an agreed minute of the orders to be made by a specified date, and if no agreement was reached, they were to provide their respective positions and submissions in support of their proposed orders.